Follow
Ralf Reilmann
Ralf Reilmann
Director
Verified email at ghi-muenster.de - Homepage
Title
Cited by
Cited by
Year
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
SJ Tabrizi, DR Langbehn, BR Leavitt, RAC Roos, A Durr, D Craufurd, ...
The Lancet Neurology 8 (9), 791-801, 2009
9392009
Huntington disease: natural history, biomarkers and prospects for therapeutics
CA Ross, EH Aylward, EJ Wild, DR Langbehn, JD Long, JH Warner, ...
Nature Reviews Neurology 10 (4), 204-216, 2014
8622014
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
SJ Tabrizi, RI Scahill, G Owen, A Durr, BR Leavitt, RA Roos, B Borowsky, ...
The Lancet Neurology 12 (7), 637-649, 2013
7942013
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
SJ Tabrizi, RI Scahill, A Durr, RAC Roos, BR Leavitt, R Jones, ...
The Lancet Neurology 10 (1), 31-42, 2011
5902011
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
SJ Tabrizi, R Reilmann, RAC Roos, A Durr, B Leavitt, G Owen, R Jones, ...
The Lancet Neurology 11 (1), 42-53, 2012
5172012
Technology in Parkinson's disease: challenges and opportunities
AJ Espay, P Bonato, FB Nahab, W Maetzler, JM Dean, J Klucken, ...
Movement Disorders 31 (9), 1272-1282, 2016
4902016
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardińas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
2332017
Diagnostic criteria for Huntington's disease based on natural history
R Reilmann, BR Leavitt, CA Ross
Movement Disorders 29 (11), 1335-1341, 2014
1882014
Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
JG De Yebenes, B Landwehrmeyer, F Squitieri, R Reilmann, A Rosser, ...
The Lancet Neurology 10 (12), 1049-1057, 2011
1702011
A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies
AJ Espay, JM Hausdorff, Á Sánchez‐Ferro, J Klucken, A Merola, P Bonato, ...
Movement Disorders 34 (5), 657-663, 2019
1562019
Tapping linked to function and structure in premanifest and symptomatic Huntington disease
N Bechtel, RI Scahill, HD Rosas, T Acharya, SJA van den Bogaard, ...
Neurology 75 (24), 2150-2160, 2010
1512010
Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease
EM Dumas, SJA van den Bogaard, ME Ruber, R Reilmann, JC Stout, ...
Human brain mapping 33 (1), 203-212, 2012
1442012
Creatine supplementation lowers brain glutamate levels in Huntington’s disease
T Merl, R Reilmann, P Saemann, A Yassouridis, J Bender, A Weindl, ...
Journal of neurology 252 (1), 36-41, 2005
1412005
TRACK-HD investigators. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
SJ Tabrizi, DR Langbehn, BR Leavitt, RA Roos, A Durr, D Craufurd, ...
Lancet Neurol 8 (9), 791-801, 2009
1402009
Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy
RI Scahill, NZ Hobbs, MJ Say, N Bechtel, SMD Henley, H Hyare, ...
Human brain mapping 34 (3), 519-529, 2013
1242013
Compensation in preclinical Huntington's disease: evidence from the track-on HD study
S Klöppel, S Gregory, E Scheller, L Minkova, A Razi, A Durr, RAC Roos, ...
EBioMedicine 2 (10), 1420-1429, 2015
1212015
Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease
A Sturrock, C Laule, J Decolongon, RD Santos, AJ Coleman, S Creighton, ...
Neurology 75 (19), 1702-1710, 2010
1162010
Coordination of prehensile forces during precision grip in Huntington's disease
AM Gordon, L Quinn, R Reilmann, K Marder
Experimental neurology 163 (1), 136-148, 2000
1152000
The structural correlates of functional deficits in early huntington's disease
C Delmaire, EM Dumas, MA Sharman, SJA Van den Bogaard, ...
Human brain mapping 34 (9), 2141-2153, 2013
992013
International guidelines for the treatment of Huntington's disease
AC Bachoud-Lévi, J Ferreira, R Massart, K Youssov, A Rosser, M Busse, ...
Frontiers in neurology 10, 710, 2019
932019
The system can't perform the operation now. Try again later.
Articles 1–20